ARCHIVES

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor: “We Will Not Be Distracted From Our Mission”

February 1, 2013

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

NCI plans to cut staff access to The Cancer Letter; insiders allege attempt at “thought control.”

November 18, 2005

In Brief: Cancer Act Renewal Nears, Appropriations Bills Lag; Interim Funding Likely For ’83 Fiscal Year

September 24, 1982

Drug Shortages: Institutions Report Halting Enrollment in Clinical Trials

March 22, 2013

NCI Drops Protocol Review Requirement To Encourage firs To List Trials On PDQ

October 24, 1997